Trial Profile
LONG-TERM FOLLOW-UP STUDY OF EARLY STAGE BREAST CANCER PATIENTS INCLUDED IN GEICAM STUDIES
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2019
Price :
$35
*
At a glance
- Drugs Lapatinib (Primary) ; Trastuzumab
- Indications Early breast cancer
- Focus Therapeutic Use
- 30 Jan 2018 New trial record